Sanctuary Advisors »

Regeneron Pharmaceuticals shares owned by Sanctuary Advisors

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Sanctuary Advisors from 13F filings

Historical chart of Sanctuary Advisors investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Sanctuary Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Sanctuary Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $40M 45k 883.19

More positions owned by Sanctuary Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Growth Etf (VUG)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Eli Lilly & Co. (LLY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Total Usd (IUSB)
Exxon Mobil Corporation (XOM)

View all positions for Sanctuary Advisors

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
State Street Corporation
Capital World Investors
Capital Research and Management Company - Division 3
Geode Capital Management
Dodge & Cox
Franklin Resources
Morgan Stanley
Loomis, Sayles and
Bank of America Corporation
Wellington Management Company
Amundi

View all funds holding Regeneron Pharmaceuticals